Good candidates Researchers studying anti-aging interventions Those investigating wound healing acceleration Researchers exploring hair and skin improvements Those combining with other peptides in tissue repair stacks Researchers with experience handling injectable compounds Poor candidates Individuals with Wilson's disease or copper metabolism disorders Those with active cancer or history of hormone-sensitive cancers (until more research exists) Pregnant or breastfeeding individuals Those taking anticoagulant medications (potential interaction concerns) Individuals with known copper allergies or sensitivities Anyone uncomfortable with self-injection or unable to maintain sterile technique When uncertain, consult a healthcare provider familiar with peptide research before beginning any protocol
Some GLP-1 drugs are also used for obesity treatment because they help reduce appetite, slow gastric emptying, and support weight loss
GI side effects peak early, often within the first 45 weeks of treatment
While the variety of GLP-1 medications makes it easy for patients to choose which method works best for them, injections may be more effective for weight loss
It is important to consult with a healthcare provider before using any GLP-1 medications, including compounded versions.They will help you assess the risks and benefits to determine if they are a good treatment option for you.* Oral GLP-1s currently available Not everyone likes or is able to take injectable medications
COLORADO The Colorado Department of Local Affairs (DOLA) Division of Local Government awarded $15 million in Energy/Mineral Impact Assistance Fund (EIAF) grants from the latest application cycle, which closed in March 2025
